IOL Chemicals & Pharmaceuticals

IOL Chemicals & Pharmaceuticals

92.35
-0.88
(-0.94%)
Market Cap
2,710.70 Cr
EPS
3.44
PE Ratio
25.74
Dividend Yield
0.87 %
Industry
Healthcare
52 Week High
107.54
52 Week Low
57.50
PB Ratio
1.60
Debt to Equity
0.05
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,641.40
#1 3,93,826.80
34.36
#1 54,729.00
9.71
#1 10,980
-19.84
46.65
6,132.50
1,62,798.60
70.57
9,712.00
18.67
2,191
26.74
37.51
1,564.00
1,26,325.50
23.42
28,409.50
7.12
5,291
9.88
62.75
3,623.00
1,22,618.80
60.70
11,539.40
6.99
1,911
19.91
57.93
1,260.40
1,05,189.30
#1 18.50
33,741.20
16.73
5,725
1.26
53.20
2,472.60
1,02,051.30
53.98
12,744.20
#1 20.90
2,007
-18.14
44.22
988.80
99,496.40
21.34
23,511.00
18.55
4,615
2.60
57.97
1,961.60
89,585.40
24.20
22,909.50
13.74
3,306
#1 51.64
53.80
33,265.00
70,685.80
48.63
6,684.70
9.64
1,414
11.55
48.48
5,347.50
63,937.40
28.11
13,458.30
3.70
2,216
21.39
68.13
Forecast
Actual
Growth Rate
Revenue Growth
-2.83 %
Net Income Growth
-24.78 %
Cash Flow Change
-38.36 %
ROE
-28.18 %
ROCE
-26.58 %
EBITDA Margin (Avg.)
-11.29 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
579
570
547
530
596
570
552
529
511
510
532
527
532
559
Expenses
527
509
510
481
492
491
481
476
454
451
484
476
465
490
EBITDA
52
61
37
49
104
80
71
53
57
59
48
51
67
70
Operating Profit %
8 %
10 %
6 %
8 %
16 %
13 %
12 %
9 %
10 %
10 %
8 %
9 %
12 %
11 %
Depreciation
11
11
11
12
12
14
16
16
16
17
18
19
19
20
Interest
2
3
4
5
5
4
4
4
3
2
4
5
4
4
Profit Before Tax
39
47
22
33
87
61
51
32
37
40
26
28
45
46
Tax
9
12
6
9
22
15
13
9
10
10
7
7
13
12
Net Profit
30
35
16
24
65
46
38
23
28
30
19
21
31
34
EPS in ₹
5.07
5.91
2.71
4.05
11.03
7.81
6.45
3.93
4.71
5.11
3.26
3.50
1.07
1.16

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
1,962
2,022
2,244
2,382
Fixed Assets
561
752
933
1,171
Current Assets
1,081
920
1,120
1,151
Capital Work in Progress
105
90
101
22
Investments
2
20
20
21
Other Assets
1,294
1,161
1,190
1,169
Total Liabilities
1,962
2,022
2,244
2,382
Current Liabilities
513
456
560
610
Non Current Liabilities
57
58
73
85
Total Equity
1,392
1,508
1,612
1,688
Reserve & Surplus
1,334
1,449
1,553
1,629
Share Capital
59
59
59
59

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
-29
-2
6
71
Investing Activities
-121
-120
-191
-154
Operating Activities
93
122
290
179
Financing Activities
-2
-4
-93
46

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
43.69 %
48.19 %
48.19 %
48.19 %
48.19 %
48.19 %
48.19 %
48.19 %
52.62 %
52.62 %
52.62 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
2.34 %
2.18 %
1.41 %
1.39 %
1.63 %
1.49 %
1.47 %
2.59 %
DIIs
0.04 %
0.04 %
0.36 %
0.50 %
0.02 %
0.02 %
0.06 %
0.17 %
0.02 %
0.26 %
0.36 %
0.37 %
0.30 %
0.10 %
0.08 %
0.08 %
0.07 %
0.02 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
27.30 %
28.03 %
29.86 %
30.15 %
30.29 %
31.15 %
31.15 %
30.92 %
30.49 %
29.28 %
30.28 %
30.63 %
30.98 %
31.48 %
31.31 %
31.23 %
31.43 %
30.22 %
Others
28.97 %
28.24 %
26.08 %
25.66 %
25.99 %
25.14 %
25.10 %
25.23 %
21.30 %
22.26 %
18.84 %
18.62 %
19.12 %
18.84 %
18.79 %
14.58 %
14.40 %
14.54 %
No of Share Holders
1,09,092
1,27,893
1,42,022
1,45,041
1,46,437
1,48,907
1,45,692
1,43,327
1,40,177
1,26,004
1,35,397
1,34,235
1,30,003
1,28,689
1,25,979
1,26,701
1,30,002
1,25,040

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 3 6 4 4 5 0.8
Dividend Yield (%) 0.00 0.00 0.00 0.00 2.72 8.48 7.07 5.53 8.18 0.87

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
22 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
22 Aug 2025 77.10 92.35
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 94.23 95.10
16 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
16 May 2025 65.00 77.10
27 Dec 2024 SPLIT Split
2:10
11 Mar 2025 82.27 82.27
18 Feb 2025 DIVIDEND Dividend
₹ 4.00 /share
18 Feb 2025 73.57 68.18
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 72.62 73.57
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 79.07 74.06
23 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Aug 2024 74.72 93.30
16 Feb 2024 DIVIDEND Dividend
₹ 5.00 /share
16 Feb 2024 87.56 82.25
17 Feb 2023 DIVIDEND Dividend
₹ 4.00 /share
17 Feb 2023 62.59 63.30
16 Feb 2022 DIVIDEND Dividend
₹ 4.00 /share
15 Feb 2022 91.71 77.42
12 Sept 2021 DIVIDEND Dividend
₹ 2.00 /share
08 Sept 2021 142.80 110.43

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript4 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation5 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation5 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome9 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication9 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation10 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release10 days ago
Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter Ended 30Th June 202510 days ago
Un-Audited Financial Results For The Quarter Ended 30Th June 202510 days ago
Intimation Pursuant To Regulation 36(1)(B) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2025
Business Responsibility and Sustainability Reporting (BRSR)Jul 31, 2025
Reg. 34 (1) Annual Report.Jul 31, 2025
Notice Of 38Th Annual General Meeting (AGM) Of The CompanyJul 31, 2025
Board Meeting Intimation for Notice Of The Board MeetingJul 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 22, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 22, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Announcement under Regulation 30 (LODR)-Credit RatingJul 01, 2025
Closure of Trading WindowJun 26, 2025
REACH Registration For Acetic AnhydrideJun 13, 2025
IOL Awarded Ecovadis Silver Medal - Ranks Among The Top 15% Companies GloballyJun 11, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 20, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 17, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 17, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 16, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Dated 16Th May 2025May 16, 2025
Audited Financial Results For The Quarter And Year Ended 31St March 2025May 16, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 14, 2025
Board Meeting Intimation for Notice Of The Board MeetingMay 06, 2025
Intimation Under SEBI (LODR) Regulations 2015 - CDE China Approved IbuprofenApr 28, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 28, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 03, 2025
Closure of Trading WindowMar 26, 2025
Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 20, 2025
Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 20, 2025
Corporate Action-Updates on intimation of Sub division / Stock SplitMar 13, 2025
EDQM Issued CEP Certificate For QUETIAPINE FUMARATEMar 05, 2025
Corporate Action-Updates on intimation of Sub division / Stock SplitMar 05, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 14, 2025
Intimation On Communication To Members Regarding Tax Deduction At SourceFeb 14, 2025

Technical Indicators

RSI(14)
Neutral
46.92
ATR(14)
Less Volatile
4.52
STOCH(9,6)
Neutral
21.94
STOCH RSI(14)
Oversold
12.83
MACD(12,26)
Bearish
-0.97
ADX(14)
Weak Trend
18.79
UO(9)
Bearish
43.51
ROC(12)
Downtrend And Accelerating
-0.83
WillR(14)
Neutral
-78.63

Mutual Fund Holdings